Cover Image
Market Research Report
Product code 
1052229

Global Respiratory Inhaler Market Insights and Forecast to 2028

Published: | QYResearch | 111 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Respiratory Inhaler Market Insights and Forecast to 2028
Published: January 19, 2022
QYResearch
Content info: 111 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Market Analysis and Insights: Global Respiratory Inhaler Market

Due to the COVID-19 pandemic, the global Respiratory Inhaler market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Dry Powder Inhaler accounting for % of the Respiratory Inhaler global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital and Clinic segment is altered to an % CAGR throughout this forecast period.

China Respiratory Inhaler market size is valued at US$ million in 2021, while the US and Europe Respiratory Inhaler are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Respiratory Inhaler landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Respiratory Inhaler include Koninklijke Philips, Omron Healthcare, Merck, Cipla, GlaxoSmithKline, PARI Medical Holding, Teva Pharmaceutical Industries, AstraZeneca and Beximco Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Respiratory Inhaler Scope and Segment

Respiratory Inhaler market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Respiratory Inhaler market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Nebulizer

Segment by Application

  • Hospital and Clinic
  • Home Care

By Company

  • Koninklijke Philips
  • Omron Healthcare
  • Merck
  • Cipla
  • GlaxoSmithKline
  • PARI Medical Holding
  • Teva Pharmaceutical Industries
  • AstraZeneca
  • Beximco Pharmaceuticals
  • Boehringer Ingelheim

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Respiratory Inhaler Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Respiratory Inhaler Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Dry Powder Inhaler
    • 1.2.3 Metered Dose Inhaler
    • 1.2.4 Nebulizer
  • 1.3 Market by Application
    • 1.3.1 Global Respiratory Inhaler Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital and Clinic
    • 1.3.3 Home Care
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Respiratory Inhaler Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Respiratory Inhaler Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Respiratory Inhaler Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Respiratory Inhaler Sales by Region
    • 2.4.1 Global Respiratory Inhaler Sales by Region (2017-2022)
    • 2.4.2 Global Sales Respiratory Inhaler by Region (2023-2028)
  • 2.5 Global Respiratory Inhaler Revenue by Region
    • 2.5.1 Global Respiratory Inhaler Revenue by Region (2017-2022)
    • 2.5.2 Global Respiratory Inhaler Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Respiratory Inhaler Sales by Manufacturers
    • 3.1.1 Global Top Respiratory Inhaler Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Respiratory Inhaler Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Respiratory Inhaler in 2021
  • 3.2 Global Respiratory Inhaler Revenue by Manufacturers
    • 3.2.1 Global Respiratory Inhaler Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Respiratory Inhaler Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Respiratory Inhaler Revenue in 2021
  • 3.3 Global Respiratory Inhaler Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Respiratory Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Respiratory Inhaler Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Respiratory Inhaler Sales by Type
    • 4.1.1 Global Respiratory Inhaler Historical Sales by Type (2017-2022)
    • 4.1.2 Global Respiratory Inhaler Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • 4.2 Global Respiratory Inhaler Revenue by Type
    • 4.2.1 Global Respiratory Inhaler Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Respiratory Inhaler Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • 4.3 Global Respiratory Inhaler Price by Type
    • 4.3.1 Global Respiratory Inhaler Price by Type (2017-2022)
    • 4.3.2 Global Respiratory Inhaler Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Respiratory Inhaler Sales by Application
    • 5.1.1 Global Respiratory Inhaler Historical Sales by Application (2017-2022)
    • 5.1.2 Global Respiratory Inhaler Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • 5.2 Global Respiratory Inhaler Revenue by Application
    • 5.2.1 Global Respiratory Inhaler Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Respiratory Inhaler Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • 5.3 Global Respiratory Inhaler Price by Application
    • 5.3.1 Global Respiratory Inhaler Price by Application (2017-2022)
    • 5.3.2 Global Respiratory Inhaler Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Respiratory Inhaler Market Size by Type
    • 6.1.1 North America Respiratory Inhaler Sales by Type (2017-2028)
    • 6.1.2 North America Respiratory Inhaler Revenue by Type (2017-2028)
  • 6.2 North America Respiratory Inhaler Market Size by Application
    • 6.2.1 North America Respiratory Inhaler Sales by Application (2017-2028)
    • 6.2.2 North America Respiratory Inhaler Revenue by Application (2017-2028)
  • 6.3 North America Respiratory Inhaler Market Size by Country
    • 6.3.1 North America Respiratory Inhaler Sales by Country (2017-2028)
    • 6.3.2 North America Respiratory Inhaler Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Respiratory Inhaler Market Size by Type
    • 7.1.1 Europe Respiratory Inhaler Sales by Type (2017-2028)
    • 7.1.2 Europe Respiratory Inhaler Revenue by Type (2017-2028)
  • 7.2 Europe Respiratory Inhaler Market Size by Application
    • 7.2.1 Europe Respiratory Inhaler Sales by Application (2017-2028)
    • 7.2.2 Europe Respiratory Inhaler Revenue by Application (2017-2028)
  • 7.3 Europe Respiratory Inhaler Market Size by Country
    • 7.3.1 Europe Respiratory Inhaler Sales by Country (2017-2028)
    • 7.3.2 Europe Respiratory Inhaler Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Respiratory Inhaler Market Size by Type
    • 8.1.1 Asia Pacific Respiratory Inhaler Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Respiratory Inhaler Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Respiratory Inhaler Market Size by Application
    • 8.2.1 Asia Pacific Respiratory Inhaler Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Respiratory Inhaler Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Respiratory Inhaler Market Size by Region
    • 8.3.1 Asia Pacific Respiratory Inhaler Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Respiratory Inhaler Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Respiratory Inhaler Market Size by Type
    • 9.1.1 Latin America Respiratory Inhaler Sales by Type (2017-2028)
    • 9.1.2 Latin America Respiratory Inhaler Revenue by Type (2017-2028)
  • 9.2 Latin America Respiratory Inhaler Market Size by Application
    • 9.2.1 Latin America Respiratory Inhaler Sales by Application (2017-2028)
    • 9.2.2 Latin America Respiratory Inhaler Revenue by Application (2017-2028)
  • 9.3 Latin America Respiratory Inhaler Market Size by Country
    • 9.3.1 Latin America Respiratory Inhaler Sales by Country (2017-2028)
    • 9.3.2 Latin America Respiratory Inhaler Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Respiratory Inhaler Market Size by Type
    • 10.1.1 Middle East and Africa Respiratory Inhaler Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Respiratory Inhaler Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Respiratory Inhaler Market Size by Application
    • 10.2.1 Middle East and Africa Respiratory Inhaler Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Respiratory Inhaler Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Respiratory Inhaler Market Size by Country
    • 10.3.1 Middle East and Africa Respiratory Inhaler Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Respiratory Inhaler Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Koninklijke Philips
    • 11.1.1 Koninklijke Philips Corporation Information
    • 11.1.2 Koninklijke Philips Overview
    • 11.1.3 Koninklijke Philips Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Koninklijke Philips Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Koninklijke Philips Recent Developments
  • 11.2 Omron Healthcare
    • 11.2.1 Omron Healthcare Corporation Information
    • 11.2.2 Omron Healthcare Overview
    • 11.2.3 Omron Healthcare Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Omron Healthcare Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Omron Healthcare Recent Developments
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Overview
    • 11.3.3 Merck Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Merck Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merck Recent Developments
  • 11.4 Cipla
    • 11.4.1 Cipla Corporation Information
    • 11.4.2 Cipla Overview
    • 11.4.3 Cipla Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Cipla Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Cipla Recent Developments
  • 11.5 GlaxoSmithKline
    • 11.5.1 GlaxoSmithKline Corporation Information
    • 11.5.2 GlaxoSmithKline Overview
    • 11.5.3 GlaxoSmithKline Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 GlaxoSmithKline Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 GlaxoSmithKline Recent Developments
  • 11.6 PARI Medical Holding
    • 11.6.1 PARI Medical Holding Corporation Information
    • 11.6.2 PARI Medical Holding Overview
    • 11.6.3 PARI Medical Holding Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 PARI Medical Holding Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 PARI Medical Holding Recent Developments
  • 11.7 Teva Pharmaceutical Industries
    • 11.7.1 Teva Pharmaceutical Industries Corporation Information
    • 11.7.2 Teva Pharmaceutical Industries Overview
    • 11.7.3 Teva Pharmaceutical Industries Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Teva Pharmaceutical Industries Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Teva Pharmaceutical Industries Recent Developments
  • 11.8 AstraZeneca
    • 11.8.1 AstraZeneca Corporation Information
    • 11.8.2 AstraZeneca Overview
    • 11.8.3 AstraZeneca Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 AstraZeneca Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 AstraZeneca Recent Developments
  • 11.9 Beximco Pharmaceuticals
    • 11.9.1 Beximco Pharmaceuticals Corporation Information
    • 11.9.2 Beximco Pharmaceuticals Overview
    • 11.9.3 Beximco Pharmaceuticals Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Beximco Pharmaceuticals Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Beximco Pharmaceuticals Recent Developments
  • 11.10 Boehringer Ingelheim
    • 11.10.1 Boehringer Ingelheim Corporation Information
    • 11.10.2 Boehringer Ingelheim Overview
    • 11.10.3 Boehringer Ingelheim Respiratory Inhaler Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Boehringer Ingelheim Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Boehringer Ingelheim Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Respiratory Inhaler Industry Chain Analysis
  • 12.2 Respiratory Inhaler Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Respiratory Inhaler Production Mode & Process
  • 12.4 Respiratory Inhaler Sales and Marketing
    • 12.4.1 Respiratory Inhaler Sales Channels
    • 12.4.2 Respiratory Inhaler Distributors
  • 12.5 Respiratory Inhaler Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Respiratory Inhaler Industry Trends
  • 13.2 Respiratory Inhaler Market Drivers
  • 13.3 Respiratory Inhaler Market Challenges
  • 13.4 Respiratory Inhaler Market Restraints

14 Key Findings in The Global Respiratory Inhaler Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Respiratory Inhaler Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Dry Powder Inhaler
  • Table 3. Major Manufacturers of Metered Dose Inhaler
  • Table 4. Major Manufacturers of Nebulizer
  • Table 5. Global Respiratory Inhaler Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Respiratory Inhaler Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Respiratory Inhaler Sales by Region (2017-2022) & (K Units)
  • Table 8. Global Respiratory Inhaler Sales Market Share by Region (2017-2022)
  • Table 9. Global Respiratory Inhaler Sales by Region (2023-2028) & (K Units)
  • Table 10. Global Respiratory Inhaler Sales Market Share by Region (2023-2028)
  • Table 11. Global Respiratory Inhaler Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Respiratory Inhaler Revenue Market Share by Region (2017-2022)
  • Table 13. Global Respiratory Inhaler Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global Respiratory Inhaler Revenue Market Share by Region (2023-2028)
  • Table 15. Global Respiratory Inhaler Sales by Manufacturers (2017-2022) & (K Units)
  • Table 16. Global Respiratory Inhaler Sales Share by Manufacturers (2017-2022)
  • Table 17. Global Respiratory Inhaler Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global Respiratory Inhaler Revenue Share by Manufacturers (2017-2022)
  • Table 19. Respiratory Inhaler Price by Manufacturers (2017-2022) &(USD/Unit)
  • Table 20. Global Respiratory Inhaler Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Respiratory Inhaler by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Inhaler as of 2021)
  • Table 22. Respiratory Inhaler Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Respiratory Inhaler Product Offered
  • Table 24. Date of Manufacturers Enter into Respiratory Inhaler Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Respiratory Inhaler Sales by Type (2017-2022) & (K Units)
  • Table 27. Global Respiratory Inhaler Sales by Type (2023-2028) & (K Units)
  • Table 28. Global Respiratory Inhaler Sales Share by Type (2017-2022)
  • Table 29. Global Respiratory Inhaler Sales Share by Type (2023-2028)
  • Table 30. Global Respiratory Inhaler Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global Respiratory Inhaler Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global Respiratory Inhaler Revenue Share by Type (2017-2022)
  • Table 33. Global Respiratory Inhaler Revenue Share by Type (2023-2028)
  • Table 34. Respiratory Inhaler Price by Type (2017-2022) & (USD/Unit)
  • Table 35. Global Respiratory Inhaler Price Forecast by Type (2023-2028) & (USD/Unit)
  • Table 36. Global Respiratory Inhaler Sales by Application (2017-2022) & (K Units)
  • Table 37. Global Respiratory Inhaler Sales by Application (2023-2028) & (K Units)
  • Table 38. Global Respiratory Inhaler Sales Share by Application (2017-2022)
  • Table 39. Global Respiratory Inhaler Sales Share by Application (2023-2028)
  • Table 40. Global Respiratory Inhaler Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global Respiratory Inhaler Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global Respiratory Inhaler Revenue Share by Application (2017-2022)
  • Table 43. Global Respiratory Inhaler Revenue Share by Application (2023-2028)
  • Table 44. Respiratory Inhaler Price by Application (2017-2022) & (USD/Unit)
  • Table 45. Global Respiratory Inhaler Price Forecast by Application (2023-2028) & (USD/Unit)
  • Table 46. North America Respiratory Inhaler Sales by Type (2017-2022) & (K Units)
  • Table 47. North America Respiratory Inhaler Sales by Type (2023-2028) & (K Units)
  • Table 48. North America Respiratory Inhaler Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America Respiratory Inhaler Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America Respiratory Inhaler Sales by Application (2017-2022) & (K Units)
  • Table 51. North America Respiratory Inhaler Sales by Application (2023-2028) & (K Units)
  • Table 52. North America Respiratory Inhaler Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America Respiratory Inhaler Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America Respiratory Inhaler Sales by Country (2017-2022) & (K Units)
  • Table 55. North America Respiratory Inhaler Sales by Country (2023-2028) & (K Units)
  • Table 56. North America Respiratory Inhaler Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America Respiratory Inhaler Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe Respiratory Inhaler Sales by Type (2017-2022) & (K Units)
  • Table 59. Europe Respiratory Inhaler Sales by Type (2023-2028) & (K Units)
  • Table 60. Europe Respiratory Inhaler Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe Respiratory Inhaler Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe Respiratory Inhaler Sales by Application (2017-2022) & (K Units)
  • Table 63. Europe Respiratory Inhaler Sales by Application (2023-2028) & (K Units)
  • Table 64. Europe Respiratory Inhaler Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe Respiratory Inhaler Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe Respiratory Inhaler Sales by Country (2017-2022) & (K Units)
  • Table 67. Europe Respiratory Inhaler Sales by Country (2023-2028) & (K Units)
  • Table 68. Europe Respiratory Inhaler Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe Respiratory Inhaler Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific Respiratory Inhaler Sales by Type (2017-2022) & (K Units)
  • Table 71. Asia Pacific Respiratory Inhaler Sales by Type (2023-2028) & (K Units)
  • Table 72. Asia Pacific Respiratory Inhaler Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific Respiratory Inhaler Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Respiratory Inhaler Sales by Application (2017-2022) & (K Units)
  • Table 75. Asia Pacific Respiratory Inhaler Sales by Application (2023-2028) & (K Units)
  • Table 76. Asia Pacific Respiratory Inhaler Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Respiratory Inhaler Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Respiratory Inhaler Sales by Region (2017-2022) & (K Units)
  • Table 79. Asia Pacific Respiratory Inhaler Sales by Region (2023-2028) & (K Units)
  • Table 80. Asia Pacific Respiratory Inhaler Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Respiratory Inhaler Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America Respiratory Inhaler Sales by Type (2017-2022) & (K Units)
  • Table 83. Latin America Respiratory Inhaler Sales by Type (2023-2028) & (K Units)
  • Table 84. Latin America Respiratory Inhaler Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America Respiratory Inhaler Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America Respiratory Inhaler Sales by Application (2017-2022) & (K Units)
  • Table 87. Latin America Respiratory Inhaler Sales by Application (2023-2028) & (K Units)
  • Table 88. Latin America Respiratory Inhaler Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America Respiratory Inhaler Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America Respiratory Inhaler Sales by Country (2017-2022) & (K Units)
  • Table 91. Latin America Respiratory Inhaler Sales by Country (2023-2028) & (K Units)
  • Table 92. Latin America Respiratory Inhaler Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Respiratory Inhaler Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa Respiratory Inhaler Sales by Type (2017-2022) & (K Units)
  • Table 95. Middle East and Africa Respiratory Inhaler Sales by Type (2023-2028) & (K Units)
  • Table 96. Middle East and Africa Respiratory Inhaler Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa Respiratory Inhaler Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Respiratory Inhaler Sales by Application (2017-2022) & (K Units)
  • Table 99. Middle East and Africa Respiratory Inhaler Sales by Application (2023-2028) & (K Units)
  • Table 100. Middle East and Africa Respiratory Inhaler Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Respiratory Inhaler Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Respiratory Inhaler Sales by Country (2017-2022) & (K Units)
  • Table 103. Middle East and Africa Respiratory Inhaler Sales by Country (2023-2028) & (K Units)
  • Table 104. Middle East and Africa Respiratory Inhaler Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Respiratory Inhaler Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. Koninklijke Philips Corporation Information
  • Table 107. Koninklijke Philips Description and Major Businesses
  • Table 108. Koninklijke Philips Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 109. Koninklijke Philips Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. Koninklijke Philips Recent Developments
  • Table 111. Omron Healthcare Corporation Information
  • Table 112. Omron Healthcare Description and Major Businesses
  • Table 113. Omron Healthcare Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 114. Omron Healthcare Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. Omron Healthcare Recent Developments
  • Table 116. Merck Corporation Information
  • Table 117. Merck Description and Major Businesses
  • Table 118. Merck Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 119. Merck Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Merck Recent Developments
  • Table 121. Cipla Corporation Information
  • Table 122. Cipla Description and Major Businesses
  • Table 123. Cipla Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 124. Cipla Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Cipla Recent Developments
  • Table 126. GlaxoSmithKline Corporation Information
  • Table 127. GlaxoSmithKline Description and Major Businesses
  • Table 128. GlaxoSmithKline Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 129. GlaxoSmithKline Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. GlaxoSmithKline Recent Developments
  • Table 131. PARI Medical Holding Corporation Information
  • Table 132. PARI Medical Holding Description and Major Businesses
  • Table 133. PARI Medical Holding Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 134. PARI Medical Holding Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. PARI Medical Holding Recent Developments
  • Table 136. Teva Pharmaceutical Industries Corporation Information
  • Table 137. Teva Pharmaceutical Industries Description and Major Businesses
  • Table 138. Teva Pharmaceutical Industries Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 139. Teva Pharmaceutical Industries Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Teva Pharmaceutical Industries Recent Developments
  • Table 141. AstraZeneca Corporation Information
  • Table 142. AstraZeneca Description and Major Businesses
  • Table 143. AstraZeneca Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 144. AstraZeneca Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. AstraZeneca Recent Developments
  • Table 146. Beximco Pharmaceuticals Corporation Information
  • Table 147. Beximco Pharmaceuticals Description and Major Businesses
  • Table 148. Beximco Pharmaceuticals Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 149. Beximco Pharmaceuticals Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Beximco Pharmaceuticals Recent Developments
  • Table 151. Boehringer Ingelheim Corporation Information
  • Table 152. Boehringer Ingelheim Description and Major Businesses
  • Table 153. Boehringer Ingelheim Respiratory Inhaler Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 154. Boehringer Ingelheim Respiratory Inhaler Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. Boehringer Ingelheim Recent Developments
  • Table 156. Key Raw Materials Lists
  • Table 157. Raw Materials Key Suppliers Lists
  • Table 158. Respiratory Inhaler Distributors List
  • Table 159. Respiratory Inhaler Customers List
  • Table 160. Respiratory Inhaler Market Trends
  • Table 161. Respiratory Inhaler Market Drivers
  • Table 162. Respiratory Inhaler Market Challenges
  • Table 163. Respiratory Inhaler Market Restraints
  • Table 164. Research Programs/Design for This Report
  • Table 165. Key Data Information from Secondary Sources
  • Table 166. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Respiratory Inhaler Product Picture
  • Figure 3. Global Respiratory Inhaler Market Share by Type in 2021 & 2028
  • Figure 3. Dry Powder Inhaler Product Picture
  • Figure 4. Metered Dose Inhaler Product Picture
  • Figure 5. Nebulizer Product Picture
  • Figure 6. Global Respiratory Inhaler Market Share by Application in 2021 & 2028
  • Figure 7. Hospital and Clinic
  • Figure 8. Home Care
  • Figure 9. Respiratory Inhaler Report Years Considered
  • Figure 10. Global Respiratory Inhaler Sales 2017-2028 (K Units)
  • Figure 11. Global Respiratory Inhaler Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Respiratory Inhaler Revenue 2017-2028 (US$ Million)
  • Figure 13. Global Respiratory Inhaler Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global Respiratory Inhaler Sales Market Share by Region (2017-2022)
  • Figure 15. Global Respiratory Inhaler Sales Market Share by Region (2023-2028)
  • Figure 16. North America Respiratory Inhaler Sales YoY (2017-2028) & (K Units)
  • Figure 17. North America Respiratory Inhaler Revenue YoY (2017-2028) & (US$ Million)
  • Figure 18. Europe Respiratory Inhaler Sales YoY (2017-2028) & (K Units)
  • Figure 19. Europe Respiratory Inhaler Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific Respiratory Inhaler Sales YoY (2017-2028) & (K Units)
  • Figure 21. Asia-Pacific Respiratory Inhaler Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Latin America Respiratory Inhaler Sales YoY (2017-2028) & (K Units)
  • Figure 23. Latin America Respiratory Inhaler Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Middle East & Africa Respiratory Inhaler Sales YoY (2017-2028) & (K Units)
  • Figure 25. Middle East & Africa Respiratory Inhaler Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. The Respiratory Inhaler Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 27. The Top 5 and 10 Largest Manufacturers of Respiratory Inhaler in the World: Market Share by Respiratory Inhaler Revenue in 2021
  • Figure 28. Global Respiratory Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 29. Global Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • Figure 30. Global Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • Figure 31. Global Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • Figure 32. Global Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • Figure 33. North America Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • Figure 34. North America Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • Figure 35. North America Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • Figure 36. North America Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • Figure 37. North America Respiratory Inhaler Sales Share by Country (2017-2028)
  • Figure 38. North America Respiratory Inhaler Revenue Share by Country (2017-2028)
  • Figure 39. U.S. Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 40. Canada Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 41. Europe Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • Figure 42. Europe Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • Figure 44. Europe Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • Figure 45. Europe Respiratory Inhaler Sales Share by Country (2017-2028)
  • Figure 46. Europe Respiratory Inhaler Revenue Share by Country (2017-2028)
  • Figure 47. Germany Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 48. France Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 49. U.K. Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 50. Italy Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 51. Russia Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 52. Asia Pacific Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Respiratory Inhaler Sales Share by Region (2017-2028)
  • Figure 57. Asia Pacific Respiratory Inhaler Revenue Share by Region (2017-2028)
  • Figure 58. China Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 59. Japan Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 60. South Korea Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 61. India Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 62. Australia Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 63. Taiwan Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 64. Indonesia Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 65. Thailand Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 66. Malaysia Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 67. Philippines Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 68. Latin America Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • Figure 69. Latin America Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • Figure 70. Latin America Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • Figure 71. Latin America Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • Figure 72. Latin America Respiratory Inhaler Sales Share by Country (2017-2028)
  • Figure 73. Latin America Respiratory Inhaler Revenue Share by Country (2017-2028)
  • Figure 74. Mexico Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 75. Brazil Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 76. Argentina Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 77. Middle East and Africa Respiratory Inhaler Sales Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Respiratory Inhaler Revenue Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Respiratory Inhaler Sales Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Respiratory Inhaler Revenue Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Respiratory Inhaler Sales Share by Country (2017-2028)
  • Figure 82. Middle East and Africa Respiratory Inhaler Revenue Share by Country (2017-2028)
  • Figure 83. Turkey Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 84. Saudi Arabia Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 85. UAE Respiratory Inhaler Revenue (2017-2028) & (US$ Million)
  • Figure 86. Respiratory Inhaler Value Chain
  • Figure 87. Respiratory Inhaler Production Process
  • Figure 88. Channels of Distribution
  • Figure 89. Distributors Profiles
  • Figure 90. Bottom-up and Top-down Approaches for This Report
  • Figure 91. Data Triangulation
  • Figure 92. Key Executives Interviewed